US 8541373
BChE albumin fusions for the treatment of cocaine abuse
granted A61KA61K38/00A61P
Quick answer
US patent 8541373 (BChE albumin fusions for the treatment of cocaine abuse) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61P, A61P25/30, A61P25/36